Endometriosis: Waiting Lists

Reducing waiting lists, including for gynaecology, is a key part of the Government’s Health Mission. We are committed to putting patients first by ensuring that they are seen on time and that they have the best possible experience of care.

At the end of September 2025, the gynaecology waiting list, which includes those waiting for endometriosis treatment, stood at 575,653, with 57.1% of patient pathways waiting less than 18 weeks. This is an improvement from September 2024 where the waiting list stood at 587,887, of which 54.6% of patient pathways were waiting less than 18 weeks.

Patients waiting for an endometriosis diagnosis may receive diagnostic tests such as magnetic resonance imaging (MRI) and ultrasound, though the only definitive way to diagnose endometriosis is by a laparoscopic procedure. The laparoscopy is also used to treat endometriosis.

We will transform diagnostic services and are taking steps to support the National Health Service to increase diagnostic capacity to meet the demand for diagnostic services, including for MRI and ultrasound. This includes expanding existing community diagnostic centres (CDCs), as well as building up to five new ones in 2025/26. The plan also commits to CDCs opening 12 hours per day, seven days a week, delivering more same-day tests and consultations.

We are taking action to ensure that individuals with endometriosis not only receive a timely diagnosis but also receive timely and effective treatment.

NHS surgical hubs, funded by the Targeted Investment Fund, are specifically designed to deliver high-volume, low-complexity elective surgeries, including gynaecological procedures. These explicitly include operative laparoscopies, endometrial ablation, hysteroscopies, and laparoscopic hysterectomies. As of November 2025, over half of the 123 operational elective surgical hubs in England provide gynaecology services, and laparoscopies are a key part of this offering.

The 2025 Spending Review also confirmed over £6 billion of additional capital investment over five years across new diagnostic, elective, and urgent care capacity. This will ensure that we are able to meet women’s health needs and address the challenges across the entirety of patient pathways.